Management of Hyperglycemic Emergencies and Painful Diabetic Peripheral Neuropathy

Immediate Assessment and Stabilization

The American Diabetes Association recommends checking for life-threatening complications immediately, including assessing mental status, hydration status, presence of nausea/vomiting, ketones, arterial or venous pH, serum osmolality, and electrolytes in patients with hyperglycemia 1, 2
Calculate effective osmolality using the formula: 2[Na+ (mEq/L)] + glucose (mg/dL)/18 to assess the severity of hyperglycemia 2
A blood glucose level of 320 mg/dL with altered mental status, vomiting, or ketosis indicates diabetic ketoacidosis (DKA), a life-threatening emergency requiring immediate medical intervention 3, 4
The American College of Clinical Endocrinologists recommends beginning immediate fluid resuscitation with 0.9% sodium chloride at 15-20 mL/kg/hour during the first hour to restore circulatory volume in patients with DKA or hyperosmolar hyperglycemic state 1, 2
Start insulin therapy after excluding hypokalemia (K+ <3.3 mEq/L): IV bolus of 0.1 units/kg, followed by continuous infusion at 0.1 units/kg/hour, as recommended by the American Association of Clinical Endocrinologists 1, 2

Identify the cause of hyperglycemia, such as missed insulin doses, inadequate medication, intercurrent illness, infection, corticosteroid use, or medication non-compliance, as recommended by the European Association for the Study of Diabetes 3, 4
Increase monitoring frequency to every 4-6 hours during acute hyperglycemia, and adjust insulin regimen temporarily if necessary, as recommended by the American Diabetes Association 3, 4, 5
Ensure adequate fluid and caloric intake to prevent dehydration and electrolyte imbalances 3, 5

Optimize glycemic control as the foundational step in managing painful diabetic peripheral neuropathy, as recommended by the International Diabetes Federation 6
Duloxetine or pregabalin are the only FDA and European Medicines Agency-approved agents for diabetic neuropathic pain, as recommended by the American Academy of Neurology 6
Tricyclic antidepressants (TCAs) have confirmed efficacy through multiple randomized controlled trials and meta-analyses for the treatment of diabetic neuropathic pain, as recommended by the European Federation of Neurological Societies 6

Persistent blood glucose >300 mg/dL requires immediate medical attention, as recommended by the American College of Clinical Endocrinologists 2
Monitor for recurrent hyperglycemia patterns suggesting inadequate baseline diabetes management, and ensure follow-up with endocrinology or primary care within 1-2 weeks of acute episode, as recommended by the American Diabetes Association 2, 3, 4
Teach patients to recognize hyperglycemic symptoms and emphasize the importance of never discontinuing insulin during illness, as recommended by the American Association of Clinical Endocrinologists 1
Provide sick-day management education and structured discharge plan addressing underlying causes, as recommended by the American College of Clinical Endocrinologists 1